Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nanomodified Surfaces Seal Leg Implants Against Infection

By HospiMedica International staff writers
Posted on 07 Apr 2011
An innovative study demonstrates that nanometer-sized Titanium (Ti) topographies can be useful in increasing skin density while reducing bacteria adhesion, thus improving the efficacy of transcutaneous Ti-based orthopedic implants.

Researchers at Brown University (Providence, RI, USA;) have developed two ways in which to modify the surface of Ti leg implants to promote skin cell growth, thereby creating a natural skin layer and sealing the gap where the device has been implanted into the body. More...
The first approach involves an electron beam of titanium coating fired at the implant abutment, creating a landscape of 20-nanometer mounds. These mounds imitate the contours of natural skin and trick skin cells into colonizing the surface and growing additional keratinocytes.

The second approach is an anodization process, which involves dipping the abutment into hydrofluoric (HF) acid and passing a jolt of electric current through it. This causes the Ti atoms on the abutment's surface to disperse and then regroup as hollow, tubular structures rising perpendicularly from the abutment's surface; as with the mounds, keratinocytes can then quickly colonize the nanotubular surface. In laboratory tests, the researchers reported nearly a doubling of skin cell density on the implant surface; within five days, the keratinocyte density reached the point at which an impermeable skin layer bridging the abutment and the body had been created.

To further promote skin cell growth around the implant, the researchers developed a synthetic molecular chain to bind fibroblast growth factor 2 (FGF-2)--a single-chain polypeptide that plays a significant role in the process of wound healing and angiogenesis--to the Ti surface, while maintaining the protein's keratotic ability. In vitro tests again showed the greatest density of skin cells on abutment surfaces using the nanomodified surfaces laced with FGF-2. Moreover, the nanomodified surfaces created more surface area for FGF-2 proteins than would be available on traditional implants. The study was published ahead of print on February 11, 2011, in the Journal of Biomedical Materials Research A.

"You need to close the area where the bacteria would enter the body, and that's where the skin is,” said lead author Thomas Webster, PhD, an associate professor of engineering and orthopedics at Brown University. "You definitely have a complete layer of skin; there's no more gap for the bacteria to go through.”

Since Ti is biocompatible, it is used extensively in medical applications, including surgical implements and implants. The Ti is often alloyed with about 4% aluminum (Al), or 6% Al and 4% vanadium. Titanium also has the inherent property to osseointegrate, enabling use in dental implants; this property is also useful for orthopedic implant applications, which benefit from titanium's lower modulus of elasticity to more closely match that of the bone. As a result, skeletal loads are more evenly shared between bone and implant, leading to a lower incidence of bone degradation due to stress shielding and periprosthetic bone fractures, which occur at the boundaries of orthopedic implants.

Related Links:
Brown University



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.